The incorporation of the isoindole
core into the DNA-encoded chemical
library is highly desirable for the great potential pharmacological
characters exampled by molecules like lenalidomide. Herein, we reported
a DNA-compatible protocol for the OPA-mediated transformation of amines
into drug-like moieties represented by isoindolinone and thio-2-isoindole,
respectively. The high conversion and wide substrate-scope property
of our protocol render its feasibility in the manipulation of terminal
amines on oligonucleotide conjugates, including “cap-and-catch”
purification, sequential synthesis during DEL construction, and on-DNA
macrocyclization.